Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers

Inclusion Criteria: • Adult volunteers (18 years of age and older) who self-identify as being in general good health. Exclusion Criteria: * Volunteers with any acute illness or uncontrolled chronic disease * Volunteers with any type of cancer * Volunteers with diabetes * Volunteers with renal disease * Volunteers with liver disease * Volunteers with morbid obesity * Volunteers with autoimmune or inflammatory diseases * Volunteers with known coagulation and/or bleeding disorders (e.g., hemophilia, Von Willebrand's disease) * Volunteers currently abusing alcohol (defined as more than 3 drinks for women and more than 4 drinks for men on any given day, or 7 drinks for women and 14 drinks for men throughout the week) or taking illicit drugs * Volunteers with hereditary fibrinolytic bleeding disorders * Volunteers with altered coagulation due to the presence of direct oral anticoagulants (e.g., apixaban, rivaroxaban, dabigatran) in the blood * Volunteers on any fibrinolytic activators (e.g., Streptokinase, t-PA, Reteplase, Tenecteplase, Urokinase, APSAC, Staphylokinase) * Volunteers who have had recent surgery (within the last four weeks) * Volunteers with any injuries leading to substantial bleeding or bruising (within the last two weeks prior to blood donation) * Volunteers with bruising, wounds, or scarring around the selected venipuncture site * Volunteers deemed unfit for participation in the trial by the principal investigator * Volunteers participating in another clinical trial that would not be scientifically or medically compatible with this trial * Volunteers who have been on P2Y12 inhibitors within the last 30 days * Volunteers receiving treatment with low molecular weight heparin (e.g., enoxaparin) * Volunteers with altered coagulation due to the presence of drugs known to affect the coagulation status in the blood (see Table 1) * Volunteers who have participated in this trial previously